Browsing NTNU Open by Author "Halvorsen, Sigrun"
Now showing items 1-3 of 3
-
Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study
Rutherford, Ole-Christian Walter; Jonasson, Christian; Ghanima, Waleed Khalid; Halvorsen, Sigrun (Peer reviewed; Journal article, 2020)The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and apixaban in routine clinical practice. Methods ... -
New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Rutherford, Ole-Christian Walter; Jonasson, Christian; Ghanima, Waleed Khalid; Holst, René; Halvorsen, Sigrun (Journal article; Peer reviewed, 2018)Background Information is needed on bleeding risk factors specific for patients with atrial fibrillation (AF) treated with non-vitamin K oral anticoagulants (NOACs). We aimed to identify risk factors in a large real-world ... -
Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease
Jortveit, Jarle; Halvorsen, Sigrun; Kaldal, Anete; Pripp, Are Hugo; Govatsmark, Ragna Elise Støre; Langørgen, Jørund (Peer reviewed; Journal article, 2019)Background: Patients with established coronary artery disease (CAD) have an increased risk of new cardiovascular events. An underuse of secondary preventive drugs has been observed, and many patients may not attain the ...